Abiologics
The role involves designing and executing cell‑based and biochemical assays to evaluate Syntein™ activity and mechanism of action, while collaborating with cross‑functional teams to advance Abiologics' pipeline. The scientist will also contribute to in‑vivo and ex‑vivo pharmacology efforts and support data generation and communication across the organization.
Abiologics is a Flagship Pioneering Company that leverages artificial intelligence and chemistry to create Synteins™, a new class of supranatural, programmable biologics designed to transcend the limitations of existing biologic medicines. Their platform combines generative AI and high-throughput chemical protein synthesis to develop targeted, protease-resistant, and immune-silent therapeutics. The company focuses on therapeutic areas including oncology, immunology, and metabolic diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Abiologics.
60% above the average for this role
Scientist I, In Vitro Pharmacology
Flagship Pioneering, Inc.
Principal Scientist, In Vitro Pharmacology
Flagship Pioneering, Inc.
Research Associate / Senior Research Associate, Translational Pharmacology
Ratio Therapeutics
Scientist I – In vitro Cancer Biology
Bristol Myers Squibb
Scientist I/II in In Vitro Pharmacology
Zealand Pharma
Cell Biologist
Global Channel Management